astrocytoma: A glial tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, subependymal giant cell astrocytoma, and glioblastoma.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditions
|
178 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
178 |
4. Check minimum number of eventsNone |
178 |
5. Include endpoints |
178 |
6. Filter based on genotype QC (FinnGen only) |
161 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
- Control conditions
- not HLP_C3_ASTROCYTOMA
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Brain astrocytoma
based on the number of shared cases.
Similar with more cases:
- Brain astrocytoma, helper endpoint
- Brain astrocytoma, including Hilmo
- Brain glioblastoma and astrocytoma
- Malignant neoplasm of brain
- Malignant neoplasm of eye, brain and central nervous system
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 161 | 80 | 81 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | 39.95 | 38.20 | 41.68 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 166
- Matched controls
- 1660
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
161.1
228.0
128
34
N03AX14
ATC
levetiracetam; systemic
238.9
207.9
102
11
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
186.4
183.9
92
11
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
71.3
175.7
124
66
130
Kela drug reimbursment
Malignant tumour
+∞
174.1
135
*
L01AX03
ATC
temozolomide; systemic
+∞
160.6
127
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
3048.3
160.0
129
*
H02AB02
ATC
dexamethasone; systemic
598.7
143.6
124
8
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
106.2
123.0
65
10
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
66.5
120.1
70
18
A04AA02
ATC
granisetron; systemic, transdermal
2164.9
110.8
95
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
73.8
103.5
58
12
A03FA01
ATC
metoclopramide; systemic, rectal
24.2
101.1
112
131
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
+∞
93.9
81
*
A04AA01
ATC
ondansetron; systemic, rectal
49.0
93.7
58
18
XX3DW
NOMESCO Finland
Time consuming IT work
34.2
85.8
60
27
N03AF02
ATC
oxcarbazepine; oral
29.6
82.0
61
32
WF002
NOMESCO Finland
Radical radiotherapy
+∞
78.5
69
*
Z51.5
ICD-10 Finland
Palliative care
43.7
71.8
45
14
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
69.8
62
*
9400/3-C71.1
ICD-O-3
Astrocytoma, NOS, of frontal lobe
+∞
68.6
61
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
19.8
65.8
59
45
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
477.3
65.4
61
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
61.3
55
*
XA800
NOMESCO Finland
Neuropsychological investigation
19.5
60.9
54
40
9400/3-C71.9
ICD-O-3
Astrocytoma, NOS, of brain, NOS
+∞
58.9
53
*
AA1AD
NOMESCO Finland
CT of head and brain
11.7
57.3
111
245
ZXC95
NOMESCO Finland
Use of surgical navigator
171.7
57.1
57
5
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
+∞
56.5
51
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
48.3
44
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
+∞
46.0
42
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
20.2
45.8
38
24
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
10.5
45.2
64
94
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
+∞
39.1
36
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
36.9
34
*
N03AX18
ATC
lacosamide; systemic
94.3
34.5
37
5
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
7.4
33.3
64
129
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
380.7
32.0
31
*
9400/3-C71.2
ICD-O-3
Astrocytoma, NOS, of temporal lobe
+∞
31.2
29
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
29.0
27
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
27.9
26
*
WZC00
NOMESCO Finland
Treatment plan or consultation
5.6
27.2
98
342
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
26.8
25
*
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
+∞
26.8
25
*
ZXC40
NOMESCO Finland
Use of ultrasound
160.0
26.5
27
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
58.1
25.2
29
6
WX882
NOMESCO Finland
High dependency care
43.5
23.9
29
8
WX872
NOMESCO Finland
Intensive care
10.4
21.8
26
29
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
88.1
21.3
23
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
126.0
21.1
22
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
238.7
21.1
21
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
20.2
19
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
225.8
20.0
20
*
WZC30
NOMESCO Finland
Teaching
5.5
19.3
46
109
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
+∞
19.1
18
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
+∞
19.1
18
*
N03AB02
ATC
phenytoin; systemic
44.1
19.1
23
6
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
29.1
18.9
25
10
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
+∞
18.0
17
*
N03AG01
ATC
valproic acid; systemic, rectal
6.7
17.5
31
55
N02AA05
ATC
oxycodone; systemic
5.7
17.1
37
80
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
31.4
17.0
22
8
C71.31
ICD-10 Finland
Malignant tumor of the parietal lobe grand II glioma
+∞
17.0
16
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
188.1
16.8
17
*
A02BC02
ATC
pantoprazole; systemic
5.0
16.7
134
760
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
15.9
15
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
175.9
15.8
16
*
ZXE20
NOMESCO Finland
More than three and less than five hours
5.6
15.8
34
73
N05CD08
ATC
midazolam; nasal, systemic
28.2
15.1
20
8
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
+∞
14.8
14
*
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
14.8
14
*
N05BA09
ATC
clobazam; oral
30.4
14.6
19
7
WX402
NOMESCO Finland
General anaesthesia
3.7
14.2
61
223
R4150
NOMESCO Finland
Neuropsychological rehabilitation
20.5
13.8
20
11
C71.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of brain
+∞
13.7
13
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
13.7
13
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
13.7
13
*
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
+∞
13.7
13
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.7
13.7
58
209
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
44.0
13.4
16
*
G40.10
ICD-10 Finland
Simple partial seizures
75.8
12.8
14
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
+∞
12.7
12
*
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
+∞
12.7
12
*
ZXM40
NOMESCO Finland
Use of fluorescent substance
+∞
12.7
12
*
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
+∞
12.7
12
*
H53.4
ICD-10 Finland
Visual field defects
20.0
12.4
18
10
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
+∞
11.6
11
*
C71.81
ICD-10 Finland
Overall malignant tumor of the brain grade II glioma
+∞
11.6
11
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
11.6
11
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
11.6
11
*
N03AX23
ATC
brivaracetam; systemic
128.6
11.6
12
*
N03AF01
ATC
carbamazepine; oral, rectal
9.7
11.5
23
27
AAA10
NOMESCO Finland
Biopsy through craniotomy
+∞
10.5
10
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
10.5
10
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
58.5
9.8
11
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
9.6
44
163
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
23.3
9.5
13
6
9400/3-C71.0
ICD-O-3
Astrocytoma, NOS, of cerebrum
+∞
9.5
9
*
183
Kela drug reimbursment
Lamotrigin and topiramate
14.8
9.4
15
11
AA1BD
NOMESCO Finland
Extensive CT of head and brain
16.8
9.2
14
9
H02AB09
ATC
hydrocortisone; systemic
11.7
9.0
16
15
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
52.8
8.8
10
*
H02AB04
ATC
methylprednisolone; systemic
3.7
8.6
30
93
G91.1
ICD-10 Finland
Obstructive hydrocephalus
94.7
8.5
9
*
N76
ICPC
Neoplasm nervous system unspecified
+∞
8.4
8
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
+∞
8.4
8
*
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
+∞
8.4
8
*
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
15.5
8.4
13
9
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
23.4
8.1
11
5
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
7.9
32
109
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.7
7.8
16
20
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
12.7
7.7
13
11
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
26.4
7.7
10
*
9400/3-C71.3
ICD-O-3
Astrocytoma, NOS, of parietal lobe
+∞
7.3
7
*
A79
ICPC
Malignancy NOS
+∞
7.3
7
*
C71.80
ICD-10 Finland
Overall malignant tumor of the brain without histology
+∞
7.3
7
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
41.8
6.8
8
*
R4130
NOMESCO Finland
Speech therapy
8.4
6.8
14
18
A28
ICPC
Limited function/disability NOS
3.3
6.7
28
97
R47.0
ICD-10 Finland
Dysphasia and aphasia
15.1
6.5
10
7
G40.89
ICD-10 Finland
Other epilepsy
72.5
6.5
7
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
72.5
6.5
7
*
R4110
NOMESCO Finland
Physiotherapy
2.5
6.5
50
242
N03AX09
ATC
lamotrigine; oral
3.9
6.4
20
57
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
18.9
6.3
9
5
C71.82
ICD-10 Finland
Overall malignant tumor of the brain grade III glioma
+∞
6.3
6
*
C71.32
ICD-10 Finland
Malignant tumor of parietal lobe grade III glioma
+∞
6.3
6
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
+∞
6.3
6
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
6.3
6
*
AA5NK
NOMESCO Finland
Tractography within white matter of central nervous system
+∞
6.3
6
*
C71.91
ICD-10 Finland
Malignant tumor in unspecified location in the brain grade II glioma
+∞
6.3
6
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
6.2
26
90
R4120
NOMESCO Finland
Occupational therapy
4.0
6.1
18
49
WX002
NOMESCO Finland
Sedation and analgesia
2.8
6.0
34
140
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
55
11
74.28
98.58
1.9
2.1
—
—
—
0
0
87
112
15.22
70.70
5.9
14.8
0.60
1.48
mmol/l
1.53
69
96
64
72
13.84
55.89
4.8
9.6
23.91
25.42
mmol/l
2.37
64
72
131
576
7.04
27.74
7.4
6.7
1.20
1.21
mmol/l
1.25
119
510
95
320
5.60
27.55
2.1
1.9
—
—
—
0
0
21
0
+∞
22.39
1.0
0.0
—
—
—
0
0
123
613
4.89
19.55
2.9
2.6
—
—
estimate
—
0
0
25
20
14.49
14.97
2.1
1.4
—
—
—
0
0
132
780
4.38
14.59
18.0
7.5
3.43
4.17
e9/l
4.47
114
676
82
359
3.54
14.47
9.3
2.0
2.38
2.35
mmol/l
1.70
77
322
18
8
25.02
13.21
1.8
1.6
—
—
—
0
0
23
42
6.20
12.51
2.0
1.2
975.06
48.34
e6/l
0.48
16
32
23
42
6.20
12.51
1.9
1.1
68.06
19.43
e6/l
0.59
16
30
9
0
+∞
9.46
1.1
0.0
—
—
—
0
0
89
492
2.74
9.35
4.5
4.1
36.96
37.42
g/l
0.36
84
466
113
1414
0.37
7.59
3.4
4.4
4.91
4.68
mmol/l
1.46
103
1352
113
1410
0.38
7.32
3.4
4.4
1.40
1.42
mmol/l
0.16
102
1344
117
1422
0.40
6.27
3.5
4.8
3.04
2.82
mmol/l
1.87
105
1352
110
1339
0.47
4.71
3.1
3.7
1.35
1.27
mmol/l
0.43
99
1262
106
1294
0.50
4.20
3.9
5.4
36.15
38.16
mmol/mol
3.02
95
1245
15
49
3.27
3.92
1.6
1.5
—
—
—
0
0
7
8
9.07
3.81
1.1
1.0
—
—
—
0
0
10
20
5.25
3.75
1.1
1.2
—
—
—
0
0
89
1132
0.54
3.70
3.4
3.6
—
—
—
0
0
69
457
1.87
3.70
2.7
3.0
13.33
40.73
ng/l
1.80
46
255
26
119
2.40
3.68
8.3
6.0
—
—
—
0
0
111
1320
0.52
3.62
4.2
4.1
5.49
5.78
mmol/l
3.36
104
1237
10
21
5.00
3.62
1.1
1.2
—
—
—
0
0
15
53
3.01
3.46
1.1
1.5
—
—
—
0
0
8
18
4.61
2.83
1.1
1.1
—
—
—
0
0
31
171
2.00
2.79
1.8
1.6
—
—
—
0
0
6
11
5.61
2.56
1.0
1.3
—
—
—
0
0
20
360
0.49
2.31
3.6
4.4
4.83
7.62
mg/mmol
0.34
12
239
0
57
0.00
2.10
0.0
1.1
—
—
—
0
0
0
58
0.00
2.08
0.0
1.1
—
—
—
0
0
6
15
4.11
2.06
1.0
1.9
—
—
—
0
0
10
38
2.73
2.04
1.4
1.8
—
—
—
0
0
10
38
2.73
2.04
1.5
1.8
—
—
—
0
0
151
1589
0.45
1.99
40.7
17.4
135.83
139.54
g/l
2.67
151
1575
151
1588
0.46
1.93
39.6
17.3
4.51
4.64
e12/l
2.75
151
1559
151
1588
0.46
1.93
40.4
17.8
40.44
41.55
%
3.00
151
1574
0
52
0.00
1.92
0.0
1.3
—
10.79
—
0
10
151
1587
0.46
1.87
39.7
17.3
90.69
90.16
fl
0.84
151
1574
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
12
4.26
1.83
1.0
1.3
—
—
—
0
0
151
1586
0.47
1.81
39.5
17.4
246.44
252.82
e9/l
0.35
151
1562
31
203
1.65
1.61
2.8
2.5
4.28
2.43
e6/l
0.29
16
85
6
20
3.07
1.59
1.3
1.9
19.20
17.15
%
—
6
20
151
1398
1.89
1.55
25.4
12.6
3.90
3.95
mmol/l
1.75
151
1366
0
42
0.00
1.55
0.0
1.3
—
—
—
0
0
19
109
1.84
1.54
1.2
1.3
—
27.06
—
0
7
151
1399
1.88
1.53
26.1
12.5
139.23
139.74
mmol/l
1.36
151
1371
5
15
3.40
1.53
1.6
1.4
—
—
—
0
0
0
45
0.00
1.52
0.0
1.3
—
93.00
—
0
5
21
127
1.75
1.45
1.6
1.6
—
—
—
0
0
7
29
2.47
1.41
1.0
1.5
—
—
—
0
0
35
246
1.54
1.36
2.1
3.3
28.27
732.14
ng/l
0.87
15
153
21
130
1.70
1.34
1.9
1.6
—
—
—
0
0
0
41
0.00
1.33
0.0
1.5
—
—
—
0
0
8
34
2.42
1.31
3.0
2.3
3.34
3.92
g/l
—
8
34
31
216
1.54
1.26
2.8
2.4
0.57
0.71
e6/l
0.27
16
98
46
350
1.43
1.22
2.5
2.5
0.14
0.23
e6/l
0.52
32
248
5
110
0.44
1.18
1.2
1.4
—
—
—
0
0
28
389
0.66
1.17
1.5
1.7
—
—
—
0
0
8
41
2.00
1.10
2.8
2.0
200.38
173.83
%
—
8
41
120
1302
0.72
1.07
4.3
5.0
1.57
1.76
mu/l
1.56
113
1227
9
45
2.06
1.07
2.0
1.8
107.33
94.31
%
—
9
45
9
152
0.57
0.94
3.7
2.0
30.22
28.91
u/l
—
9
121
52
430
1.30
0.81
2.8
2.7
—
—
—
0
0
149
1418
1.50
0.80
23.7
11.3
19.59
21.92
mg/l
0.55
141
1106
142
1341
1.41
0.79
23.6
10.1
97.45
91.92
ml/min/173m2
3.11
133
1200
11
172
0.61
0.79
1.1
2.2
—
—
—
0
0
61
708
0.78
0.78
2.5
3.1
89.21
87.91
ug/l
0.03
55
677
5
24
2.12
0.75
1.2
1.3
—
—
—
0
0
5
27
1.88
0.69
1.2
1.3
—
—
—
0
0
12
78
1.58
0.67
1.4
1.5
—
—
—
0
0
15
211
0.68
0.67
2.2
2.5
0.61
0.77
ug/l
—
8
108
29
362
0.76
0.64
3.1
3.3
0.00
0.00
estimate
—
10
131
0
20
0.00
0.61
0.0
1.3
—
—
—
0
0
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
0
21
0.00
0.60
0.0
1.6
—
7.28
—
0
21
26
325
0.76
0.58
1.7
2.3
—
—
—
0
0
29
356
0.78
0.56
1.8
2.4
—
—
—
0
0
52
594
0.82
0.54
2.4
2.5
75.01
73.79
nmol/l
0.12
46
547
63
702
0.83
0.50
3.3
3.2
0.00
0.00
estimate
-0.00
12
136
22
275
0.77
0.49
2.5
3.3
21.49
24.28
%
—
10
101
65
718
0.84
0.46
3.3
3.3
0.00
0.00
estimate
-0.00
12
128
13
95
1.40
0.45
3.1
2.8
—
—
—
0
0
36
419
0.82
0.44
3.2
2.6
0.00
0.00
estimate
—
10
114
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.6
—
8.69
—
0
16
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
21
257
0.79
0.41
1.4
1.5
—
—
—
0
0
65
712
0.86
0.40
3.1
3.2
0.00
0.00
estimate
-0.00
12
136
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
5
36
1.40
0.38
1.6
1.2
—
—
—
0
0
19
155
1.25
0.34
1.8
1.6
1267.80
1091.98
nmol/l
—
10
123
101
1063
0.87
0.33
3.8
4.3
14.23
14.58
pmol/l
0.72
94
999
50
550
0.87
0.32
3.3
2.9
0.00
0.00
estimate
-0.00
11
119
7
98
0.70
0.32
1.0
1.0
—
—
—
0
0
18
210
0.84
0.23
1.3
2.3
—
—
—
0
0
7
94
0.73
0.23
3.9
1.8
0.06
0.19
e6/l
—
7
87
0
11
0.00
0.21
0.0
4.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
153.46
—
0
12
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
29
321
0.88
0.20
2.8
2.9
1.02
1.02
kg/l
0.66
19
210
121
1242
0.90
0.19
32.6
14.0
13.34
13.28
%
0.24
121
1228
36
331
1.11
0.18
1.4
1.5
17.37
20.67
nmol/l
0.83
31
295
50
530
0.92
0.16
1.7
1.9
93.19
99.54
pmol/l
0.46
27
273
6
80
0.74
0.16
1.0
1.1
1.43
1.47
g/l
—
6
80
6
80
0.74
0.16
1.0
1.1
0.78
0.90
g/l
—
6
80
9
79
1.15
0.15
1.3
1.4
—
—
—
0
0
11
128
0.85
0.14
1.6
2.9
6.05
5.74
kpa
0.57
11
123
5
44
1.14
0.10
1.2
1.1
—
3.73
—
0
9
150
1515
0.90
0.09
20.7
9.1
29.21
28.27
u/l
0.23
150
1481
5
60
0.83
0.08
1.2
1.5
—
—
—
0
0
6
74
0.80
0.07
1.3
2.9
25.33
24.44
mmol/l
—
6
74
9
85
1.06
0.07
1.7
2.3
8.77
9.75
ug/l
—
9
75
30
310
0.96
0.03
2.0
2.1
1.84
2.56
mg/l
2.47
24
272
15
144
1.05
0.00
4.7
3.9
24.78
31.28
%
—
9
96
31
311
1.00
0.00
1.5
1.7
1.19
0.86
mg/l
0.32
22
234
17
175
0.97
0.00
2.1
2.5
10.42
6.11
umol/l
0.27
12
156
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
5
52
0.96
0.00
2.0
1.9
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
67.20
—
0
9
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
7.08
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
578.75
—
0
8
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
7.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
12.12
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
40.42
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
187.20
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.30
—
0
5
151
1510
1.00
-0.00
30.4
13.3
69.56
75.21
umol/l
3.25
151
1492
7
74
0.94
-0.00
3.9
3.5
67.29
81.82
ng/l
—
7
64
0
6
0.00
-0.00
0.0
1.7
—
14.13
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_ASTROCYTOMA – Brain astrocytoma
GWS hits: 1
This endpoint is excluded from FinRegistry analyses (omitted endpoint).